TEN Holdings, Inc. (Nasdaq: XHLD) and ImageneBio, Inc. (Nasdaq: IMA) are scheduled to participate in the H.C. Wainwright 28th Annual Global Investment Conference in New York in September 2026. TEN Holdings Chairman and Chief Executive Officer Virgilio Torres will deliver a live company presentation and meet investors during the Sept. 14-16 event at the Lotte New York Palace Hotel. ImageneBio chief executive officer Kristin Yarema, Ph.D., will take part in a fireside chat on Sept. 14 at 3:30 p.m. ET, while management also holds one-on-one meetings. ImageneBio is developing olevaprubart, a non-depleting anti-OX40 monoclonal antibody, and is conducting a Phase 2b trial in moderate-to-severe atopic dermatitis.